Facts

• Segment: Healthcare
• Country: Israel
• Founded: 2010
• Website: https://bio-xtreme.com/

Profile sections

• Summary
• Market context
• Facts
• Funding
• Investors
• Context / Market Position
• Events
• Team
• Relationships
• Context tags
• Customers and deployments
• Sources

Summary

BioXtreme develops robotic rehabilitation systems for upper-limb and hand recovery after stroke, traumatic brain injury and other neurological conditions. Its PlaXtreme device uses error-augmentation therapy, force feedback and real-time data to support motor learning in clinical rehabilitation workflows.

Market context

Bioxtreme is a focused neurorehabilitation robotics company rather than a broad assistive-device vendor. Plaxtreme extends its error-augmentation approach into hand recovery, where measurable gains in grasp, release, grip, and pinch function are clinically meaningful.

Facts

• Website: https://bio-xtreme.com/
• HQ: Petah Tikva, Israel
• Founded: 2010
• Segment: Healthcare
• Known funding rounds: 1

Funding

• 2026-04-21 - Strategic investment - $15M - Bioxtreme secures Serra Holding-led strategic investment as total funding reaches USD 15 million - source: globenewswire.com

Investors

• Serra Holding - Lead - Angel / Individual - 1 funding event - first seen 2026-04-21

Upper-limb rehabilitation robotics company

Bioxtreme develops robotic rehabilitation systems for upper-limb therapy, using error-augmentation technology for stroke and neurological recovery.

• Target environment: Rehabilitation clinics, hospitals, neurorehabilitation programs and upper-limb therapy settings.
• Deployment model: Medical rehabilitation robot product development and clinical deployment through healthcare channels.
• Customer context: Rehabilitation providers, clinicians, stroke patients, neurological injury patients and healthcare systems.
• Workflow context: Upper-limb therapy, motor learning, error augmentation, robotic assistance and post-stroke rehabilitation.
• Commercial maturity: Early medical robotics company with clinical validation claims around Dextreme upper-limb rehabilitation. Scaling depends on clinical evidence, regulatory clearance, reimbursement, therapist workflo…
• Market position: Healthcare robotics company focused on upper-limb rehabilitation rather than gait exoskeletons or surgical robots.
• Adoption constraints: Adoption depends on clinical evidence, regulatory clearance, reimbursement, therapist workflow fit, device cost and patient outcomes.
• Adjacent context: Adjacent context includes rehabilitation robotics, upper-limb therapy robots, neurorehabilitation devices and assistive medical robotics.
• Source confidence: medium

Events

• 2026-04-21 - Funding - Bioxtreme secures Serra Holding-led strategic investment as total funding reaches USD 15 million - Bioxtreme announced a strategic investment led by Serra Holding.
• 2026-04-21 - Product Launch - Bioxtreme introduces Plaxtreme robotic hand-rehabilitation system - Bioxtreme introduced Plaxtreme, a robotic rehabilitation device for restoring functional hand movement.
• 2024-06-03 - Deployment - Bioxtreme and Villa Beretta launch Plaxtreme clinical trial for stroke and traumatic brain injury rehabilitation - The trial focuses on stroke and traumatic brain injury patients in sub-acute a…
• 2020-02-17 - Regulatory - Bioxtreme receives FDA clearance for DeXtreme rehabilitation robotic device - Bioxtreme's DeXtreme neurorehabilitation robotic device is listed as FDA approved.

Team

• Eyal Samuel Shachar - CEO - Current operating leader for BioXtreme's rehabilitation robotics platform and error-augmentation approach to neurorehabilitation.
• Nini Bluman - CTO & Founder
• Oded Lazarovich - VP Product

Relationships

• deployment_partner - Joint clinical trial partnership for Plaxtreme stroke and TBI rehabilitation (Villa Beretta RRII).

Context tags

• Medical device robotics supplier - Peer Group
• Medical device supplier layer - Stack Layer
• Medical device automation - Workflow
• Healthcare operations - Customer Environment

Customers and deployments

• Deployment Event - 1 source-backed deployment event - 2024-06-03 - Bioxtreme and Villa Beretta launch Plaxtreme clinical trial for stroke and traumatic brain injury rehabilitation - source posture: Third Party Reported